Claude Announces 2013 Annual Production Trading Symbols

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
Claude Announces 2013 Annual Production

Trading Symbols
TSX - CRJ
OTCQB - CLGRF
SASKATOON, Jan. 29, 2014 /PRNewswire/ - Claude Resources Inc. ("Claude" and or the "Company") (TSX: CRJ; OTCQB: CLGRF) today announced fourth quarter and full year 2013 gold production results and highlights. All dollar figures are in Canadian dollars.

Full year 2013 gold sales were 44,823 ounces at an average gold price of approximately $1,423 per ounce from its Seabee Gold Operation in Saskatchewan, Canada. In 2013, the Seabee Gold Operation achieved record mill throughput of 280,054 tonnes at a head grade of 5.11 grams per tonne with an average mill recovery of 95.25 percent to produce approximately 43,850 ounces.

During the fourth quarter, gold sales were 13,209 at an average price of $1,325. Production in the quarter was 12,789 ounces of gold at a head grade of 5.60 grams per tonne. Further operating and financial results will be announced in March of 2014.

2013 Highlights:

Achieved record mine production of 286,145 tonnes with a 10 percent reduction in mine site personnel;
Record mill throughput of 280,054 tonnes at a head grade of 5.11 grams per tonne;
Gold production of 43,850;
Gold sales of 44,823 at an average gold price of $1,423;
Increased mineral reserves by 78 percent or 243,000 ounces of gold from the Santoy Gap;
Decreased overall corporate expenditures by approximately 20 percent;
Exceeded safety and environment targets and set Company records;
Continued development and drilling on the Santoy Gap deposit;
Initiated new mining method in the L62 zone to reduce dilution rates, development requirements and total all in costs; and
Completed major shaft extension from 550 metres to 980 metres.
Neil McMillan, President and CEO, stated, "We made significant progress in 2013 at the Seabee Gold Operation. I am proud to say that we exceeded our safety and environment targets; successfully completed several upgrades including the completion of the shaft extension project; mining and development crews were well below budgeted expenditures and the Company decreased its overall corporate costs substantially. We are not satisfied with our gold production which was below budget in large part due to lower than anticipated grades from the Seabee Mine. The Company has and continues to make efforts to improve mining grade and lower dilution rates one of which is a change in the mining techniques at the Seabee Mine. In 2014, the Company will continue to focus on more efficient operations and increasing margins while advancing the Santoy Gap towards production."

2014 Outlook

At the Seabee Gold Operation in 2014, the Company plans to produce between 47,000 and 51,000 ounces of gold from the Seabee Mine and the Santoy Mine Complex, an increase of approximately 10 percent from 2013. Unit cash cost are expected to be $850 to $950 per ounce. Based on current gold prices, the Company will focus on increasing margins and lowering capital expenditures without impacting the advancement of the Santoy Gap deposit. Overall, company expenditures are budgeted to be significantly less than previous years with lower capital costs, development costs, exploration expenditures and corporate general and administration costs.

Claude Resources Inc. is a publicly traded gold exploration and mining company based in Saskatoon, Saskatchewan, whose shares trade on the Toronto Stock Exchange (TSX: CRJ) and the OTCQB (OTCQB: CLGRF). Its asset base is located entirely in Canada and since 1991, Claude has produced over 1,000,000 ounces of gold from its Seabee Gold Operation in northeastern Saskatchewan. The Company also owns 100 percent of the Amisk Gold Project in northeastern Saskatchewan.

CAUTION REGARDING FORWARD-LOOKING INFORMATION

All statements, other than statements of historical fact, contained or incorporated by reference in this news release and  constitute "forward-looking information" within the meaning of applicable Canadian securities laws and "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 (referred to herein as "forward-looking statements").  Forward-looking statements include, but are not limited to, statements with respect to the future price of gold, the estimation of mineral reserves and resources, the realization of mineral reserve estimates, the timing and amount of estimated future production, costs of production, capital expenditures, costs and timing of the development of new deposits, success of exploration activities, permitting time lines, currency exchange rate fluctuations, requirements for additional capital, government regulation of mining operations, environmental risks, unanticipated reclamation expenses, title disputes or claims and limitations on insurance coverage.  Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate" or "believes", or the negative connotation thereof or variations of such words and phrases or state that certain actions, events or results, "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative connotation thereof.

All forward-looking statements are based on various assumptions, including, without limitation, the expectations and beliefs of management, the assumed long-term price of gold, that the Company will receive required permits and access to surface rights, that the Company can access financing, appropriate equipment and sufficient labour, and that the political environment within Canada will continue to support the development of mining projects in Canada.

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Claude to be materially different from those expressed or implied by such forward-looking statements, including but not limited to:  actual results of current exploration activities; environmental risks; future prices of gold; possible variations in ore reserves, grade or recovery rates; mine development and operating risks; accidents, labour issues and other risks of the mining industry; delays in obtaining government approvals or financing or in the completion of development or construction activities; and other risks and uncertainties, including but not limited to those discussed in the section entitled "Business Risk" in the Company's Annual Information Form.  These risks and uncertainties are not, and should not be construed as being, exhaustive.

Although Claude has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.  There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.  Accordingly, readers should not place undue reliance on forward-looking statements.

Forward-looking statements in this news release are made as of the date of this news release and accordingly, are subject to change after such date.  Except as otherwise indicated by Claude, these statements do not reflect the potential impact of any non-recurring or other special items that may occur after the date hereof.  Forward-looking statements are provided for the purpose of providing information about management's current expectations and plans and allowing investors and others to get a better understanding of our operating environment.

Claude does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws.

SOURCE Claude Resources Inc.


Copyright 2014 PR Newswire
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 2

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
AI and Workforce Transformation: Zellis Connect 2026

Updated Category News Views 0

AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...

Continue Reading
53% of European Telecom Users Eye Provider Switch

Updated Category News Views 3

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
Hyundai and UEFA: Kicking Off a Game-Changing Deal

Updated Category News Views 3

Hyundai Drives Into Europe's Football Arena Football fever just turned electric with Hyundai allying itself with the UEFA Champions League. We're not talking about sidelines. We're smack dab in the center field of a multi-year partnership starting with the 2026/27 season. Folks, if you think this is just Hyundai shaking hands for brand exposure, think again. This is...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 4

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 2

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
AION UT Sets New Safety Standard in Euro NCAP 2026

Updated Category News Views 1

The New Gold Standard in Safety for Small EVs Hop into your favorite auto forum and you'll hear more than a buzz—it's a full-blown ruckus. The reason? GAC’s AION UT just nabbed a 2026 Euro NCAP Five-Star Safety Rating. Now, this isn’t just another accolade in a crowded trophy room; it’s a statement, a seismic shift in how small electric vehicles stack up in terms...

Continue Reading
Sky Labs' CART Monitor Advances BP Monitoring Tech

Updated Category News Views 0

Cuffless BP Monitoring: Changing the Game for AF and HF Ever thought a finger ring could revolutionize blood pressure monitoring? Well, welcome to the future—Sky Labs' ring-type CART monitor has just rocked the scene at the ESC Congress 2026 in Munich. This isn't sci-fi, folks; it's where health tech meets reality, and it's shaking the very foundations of how we manage...

Continue Reading

Top 5 Most Recently Viewed Articles

Lynkwell Boosts Growth with Strategic Investments in North America

Updated Category News Views 191

Lynkwell Amplifies Growth Plans for North American Expansion Lynkwell, a leading player in energy infrastructure, is set to embark on an exciting journey into 2025. With a focus on meeting the growing demands of the evolving electric vehicle (EV) market, Lynkwell is making significant investments to enhance its capabilities and expand its footprint across North America....

Continue Reading
Understanding the Recent Private Student Loan Trends and Insights

Updated Category News Views 197

Overview of Recent Trends in Private Student Loans In the recent semi-annual Private Student Loan Report released by Enterval Analytics, insights into the current status of private student loans reveal a stable repayment landscape. Since Enterval focuses on the private student loan market, their findings shed light on how borrowers are adapting their financial strategies...

Continue Reading
StemCyte's Groundbreaking RMAT Designation for Long COVID-19

Updated Category News Views 63

StemCyte's Major Achievement in Cord Blood Therapy StemCyte has made significant strides in regenerative medicine, specifically with its Hematopoietic Progenitor Cell (HPC) Cord Blood therapy. The company recently announced that it has received the Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) aimed at treating...

Continue Reading
Novo Nordisk Restructures to Combat Rising Competition

Updated Category News Views 214

Novo Nordisk's Significant Job Cuts Novo Nordisk, a leading pharmaceutical company in diabetes care, has announced a major workforce reduction, cutting 9,000 jobs, which amounts to about 11.5% of its employees. This decision reflects the intense market pressure the company faces from its competitor, Eli Lilly. Restructuring for Financial Efficiency The restructuring...

Continue Reading
One Helix: The Innovative Research Hub Transforming Life Sciences

Updated Category News Views 169

Elevating Research with One Helix One Helix emerges as a landmark project in life sciences, representing a new era of innovation and sustainable architecture. Located within a prominent university medical center, this facility is not just a building; it is a commitment to fostering scientific advancements. Completely leased to AstraZeneca, One Helix is designed to elevate...

Continue Reading